Literature DB >> 9030371

Sex, drugs and HIV counseling and testing: a prospective study of behavior-change among methadone-maintenance clients in New England.

R J MacGowan1, R M Brackbill, D L Rugg, N M Swanson, B Weinstein, A Couchon, J Scibak, S Molde, P McLaughlin, T Barker, R Voigt.   

Abstract

OBJECTIVES: To determine whether changes in injecting drug use and sexual behavior over a 12-month follow-up are associated with HIV counseling and testing (C and T) of injecting drug users in methadone maintenance treatment programs (MMTP) in Massachusetts and Connecticut.
METHODS: Clients were invited to participate in a longitudinal study involving five interviews. Data were also obtained by ethnographers and from clinical records. Behavioral outcomes of interest were number of drug injections, sharing of unclean 'works' (injecting equipment), number of unprotected sex partners, and number of unprotected sexual episodes. Data analyses included multiple regression, odds ratios, and quantitative analysis of text-based data.
RESULTS: Subjects reported reductions in both injecting drug use and sexual behavior Primary associations with reduced injecting drug use were remaining in the MMTP and attending HIV-positive support groups. A reduction in high-risk sexual behavior was associated with an HIV-positive test result and duration of HIV counseling in the MMTP. Increase in drug injecting use was associated with an HIV-positive test result. Inconsistent condom use was associated with enrollment in the MMTP where condoms were available only upon request and abstinence and monogamy between uninfected partners were promoted.
CONCLUSIONS: Injecting drug users who self-select to participate in MMTP and HIV C and T, two public health HIV-prevention interventions, reduce their HIV-risk behaviors. Clients should be encouraged to remain in MMTP and HIV-infected clients should attend support groups for HIV-positive persons. MMTP staff should promote a variety of safer sex behaviors and provide condoms without request.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9030371     DOI: 10.1097/00002030-199702000-00014

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

1.  Personal, cognitive, behavioral, and demographic predictors of HIV testing and STDs in homeless women.

Authors:  A M Nyamathi; J A Stein; J M Swanson
Journal:  J Behav Med       Date:  2000-04

2.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

3.  Consistency in maintaining contact with HIV-related service providers: an analysis of the AIDS Cost and Services Utilization Study (ACSUS).

Authors:  S J Niemcryk; A Bedros; K M Marconi; J F O'Neill
Journal:  J Community Health       Date:  1998-04

4.  Linking clients from HIV antibody counseling and testing to prevention services.

Authors:  R Marx; A M Hirozawa; P L Chu; G A Bolan; M H Katz
Journal:  J Community Health       Date:  1999-06

5.  Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.

Authors:  H Thiede; H Hagan; C S Murrill
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

6.  Is monogamy or committed relationship status a marker for low sexual risk among men in substance abuse treatment? Clinical and methodological considerations.

Authors:  Donald A Calsyn; Aimee N Campbell; Susan Tross; Mary A Hatch-Maillette
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

7.  Incidence of HIV among injection drug users entering drug treatment programs in four US cities.

Authors:  C S Murrill; D R Prevots; M S Miller; L A Linley; J E Royalty; M Gwinn
Journal:  J Urban Health       Date:  2001-03       Impact factor: 3.671

8.  Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting.

Authors:  André Seidenberg; Thomas Rosemann; Oliver Senn
Journal:  BMC Infect Dis       Date:  2013-01-08       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.